Johnson and Johnson expects COVID-19 vaccine data next week

Johnson and Johnson expects COVID-19 vaccine data next week

To put it plainly, the Johnson & Johnson jab could help to ramp up COVID-19 vaccination programmes significantly as it involves just one dose, and has none of the complicated storage requirements of other vaccines.

Experts expect the vaccine to show efficacy of J&J's vaccine at, or above, 80%.

J&J is planning to onboard seven factories by the end of next quarter to meet its USA dose commitment by the end of June and fulfill its European order by the end of the year, Wolk said on CNBC early Tuesday. Unlike Pfizer's (NYSE:PFE) and Moderna's (NASDAQ: MRNA) authorized vaccines, which require two doses given about three to four weeks apart, J&J's requires only one dose. Orders for hundreds of millions of doses are pending.

Johnson & Johnson said on Tuesday it would share details from its widely watched coronavirus vaccine trial soon, as the healthcare conglomerate races to develop a potential single-dose vaccine for COVID-19. "I think the definitive statement here is that we are very comfortable in meeting our commitments to those respective countries or organizations that I just outlined", referring to the US, EU and developing nations.

These include 100 million doses to the U.S. by the end of June, about 200 million doses by the end of the year to the European Union with shipments starting in April, and 200 million doses to developing countries that will begin shipping in the second half of the year.

Wolk added that pricing of the vaccine would depend on the number of doses secured by countries and organizations. It's "somewhat of a fluid situation", he added.

Merck & Co.is discontinuing development of its Covid-19 vaccine after results from a clinical trial showed disappointing results, the company said Monday. But because there are still many moving parts, the company didn't provide financial guidance for the shot, which could deliver a sizable revenue boost this year.

Actress Cicely Tyson dead at age 96
She came around, telling the AP she thought of the hat as homage to Franklin's appearance at Obama's inauguration. She played Rebecca Morgan in Sounder , a film about black sharecroppers trying to survive the Great Depression.

In all, J&J is on track to produce around 1 billion doses of the vaccine during 2021, executives said. The company has pledged to sell its vaccine on a not-for-profit basis during the pandemic.

Johnson & Johnson's fourth-quarter revenue was $22.48 billion, compared with $20.75 billion in the year-before quarter.

The company's consumer unit, which makes products such as Listerine, generated $3.6 billion in revenue, up 1.4% from a year earlier.

Adjusted net income came to $4.97 billion, or $1.86 per share, easily topping the $1.81 Wall Street analysts expected.

Within pharmaceuticals, eight drugs delivered double-digit revenue growth, including Darzalex, which leapt 49%, and Stelara, which grew 30%.

The company forecast it adjusted profit for 2021 of between $9.40 and $9.60 per share and sales between $90.5 billion to $91.7 billion.

Related Articles